Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 15,500
+1,650 (11.91%)
At close: Apr 17, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 35.76 billion as of April 17, 2026. Its market cap has increased by 54.86% in one year.
Market Cap
35.76B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,500.00
Market Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 35.76B, a decrease of -38.97%. That is a compound annual growth rate of -16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 35.76B | 3.33% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ark Solutions | 68.91B |
| ADBiotech | 55.89B |
| NGeneBio | 50.03B |
| J2KBIO | 49.06B |
| Parataxis Korea | 44.13B |
| MOA Life Plus | 39.00B |
| SCM Lifescience | 38.06B |
| Kainos Medicine | 35.56B |